HOOK Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 108296 min ago

@ $0.697

Ausgestellt: 14 Feb 2024 @ 15:37

Rendite: 33.39%

Vorheriges Signal: Feb 12 - 20:32

Vorheriges Signal: Kaufen

Rendite: 4.84 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 21:32):

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform...

Stats
Tagesvolumen	2.19M
Durchschnittsvolumen	752 017
Marktkapitalisierung	89.79M
EPS	$0 ( 2024-03-20 )
Nächstes Ertragsdatum	( $-0.120 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.080
ATR14	$0.0130 (1.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Orlinger Klaus	Buy	367 300	Stock Option (Right to Buy)
2024-04-15	Aldag Jorn	Buy	971 400	Stock Option (Right to Buy)
2024-04-15	Winderlich Mark	Buy	250 000	Stock Option (Right to Buy)
2024-04-15	Winderlich Mark	Buy	50 000	Stock Option (Right to Buy)
2024-04-15	Kandera Reinhard	Buy	406 200	Stock Option (Right to Buy)

INSIDER POWER
98.82
Last 94 transactions
Buy: 7 455 375 \| Sell: 565 370

Volumen Korrelation

Lang: -0.32 (neutral)

Kurz: 0.86 (strong)

Signal:(50.109) Same movement expected

HOOKIPA Pharma Inc Korrelation

10 Am meisten positiv korreliert
TCRT	0.916
VSTA	0.914
JNCE	0.904
INFI	0.903
MPAA	0.903
VCSA	0.902
POWW	0.899
VIRX	0.899
GRAY	0.897
TOI	0.896

10 Am meisten negativ korreliert
IMMR	-0.897
PBFS	-0.892
BNIXU	-0.887
ISIG	-0.875
WEN	-0.873
CCRC	-0.872
MGI	-0.869
SEDG	-0.864
IBEX	-0.862
MSON	-0.859

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

HOOKIPA Pharma Inc Korrelation - Währung/Rohstoff

0.79
( moderate )

0.74
( moderate )

0.00
( neutral )

0.83
( strong )

-0.67
( moderate negative )

-0.69
( moderate negative )

HOOKIPA Pharma Inc Finanzdaten

Annual	2023
Umsatz:	$20.13M
Bruttogewinn:	$16.58M (82.35 %)
EPS:	$-0.860

FY	2023
Umsatz:	$20.13M
Bruttogewinn:	$16.58M (82.35 %)
EPS:	$-0.860

FY	2022
Umsatz:	$14.25M
Bruttogewinn:	$10.65M (74.72 %)
EPS:	$-0.990

FY	2021
Umsatz:	$18.45M
Bruttogewinn:	$18.45M (100.00 %)
EPS:	$-2.79

Financial Reports:

No articles found.

HOOKIPA Pharma Inc

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.